Alfasigma Signals Consumer Health Ambitions With Sofar Acquisition
Executive Summary
By acquiring fellow Italian manufacturer Sofar, Alfasigma expands its consumer health footprint and adds products and expertise in its priority gastrointestinal category.
You may also be interested in...
Italy’s Alfasigma Comes Calling After Intercept’s Cruel Summer
The Bologna-based firm is looking to grow its presence in the US as well as in gastrointestinal and liver disease as it acquires Intercept, which received a second rejection for its NASH drug OCA in June.
Supplements And Personal Care Sales Boost Italian Online Pharmacy During COVID-19
Sales of dietary supplements and personal care products helped Italy's online pharmacy channel grow by 25% in the twelve months to October 2021, IQVIA reports.
EU Business Round-Up: Bionorica's Sales Hit By COVID, Precision Takes Kwai To Austria, Alfasigma Hires Italy Chief
The latest European consumer health news: Germany's Bionorica posts double-digit sales decline due to COVID; Precision Healthcare takes Kwai to Austria; and Alfasigma hires Janssen exec to lead expanded Italy business.